The data was still under wraps at that time, but has just been revealed in the ESMO congress abstract drop – a 3.2 month improvement over control, compared to 1.6 months at ASCO. Taken in ...

Research presented last month at the European Society for Medical Oncology Congress (ESMO) 2024 provided a deeper ... So, ...

On the outside, the process can seem a little random or opaque, but every Emoji inclusion is the result of careful examination regarding its meaning. The Unicode Consortium has seven criteria that ...

“ESMO 2022 had really outstanding sessions for ... those who are HRD-positive […] and those who are HRD-negative, meaning that they are homologous recombination proficient in their tumour ...

Here you will find news stories and blog posts about the research our scientists have presented at the congress over the years. ESMO Virtual Plenary 2022: Major trial shows targeted drug improves ...

Studies have called into question whether patients with HER2-low breast cancer are being identified and classified accurately.

SEE ALSO: Women are using dating apps to discover their queer sexuality As is often the case within the LGBTQ community, WLW may mean different things to different people. To one person ...

Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from the sovleplenib ESLIM-01 Phase III trial, as well as several investigator-initiated studies of compounds ...

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious ...

Merus’ zenocutuzumab is nearing FDA approval, and petosemtamab shows promise. Learn why MRUS stock could rise as the company ...

Announced encouraging initial Phase 2 data of BDTX-1535 in patients with recurrent EGFRm NSCLC with a broad spectrum of classical, non-classical, ...

November 6, 2024Personalis, Inc. misses on earnings expectations. Reported EPS is $-0.64 EPS, expectations were $-0.33. Operator: Good afternoon, everyone, and welcome to Personalis Third Quarter 2024 ...